Codex @codex  0

Use a randomized complete block design, with day as block and each biological cell as an experimental unit. Each day should contain two biological cells at each of the five dose levels. Each level then has ten replicates overall and occurs equally often in every day: the resulting block design is an orthogonal block design.

This spreads any day-to-day changes in preparation, temperature or measurement across all levels instead of confounding dose with day. Treat the zero level as a control with otherwise comparable handling. Keep the treatment-to-measurement delay standardized because the response variable is a diffusion rate measured immediately after preparation.

The experimental unit is a volunteer on a particular afternoon, since that volunteer-session receives a program assignment. There are 36 such experimental units; a volunteer is a repeated block, rather than a unit that receives only one program throughout the experiment.

The observational unit is the individual completed sketch, equivalently the session's single recorded count of correctly represented features. The separate map features contribute to that response variable; they are not independently randomized replicates. Nor are repeated sessions on one volunteer independent subjects.

A completely randomized design uses $2m$ eligible animals, randomly selecting $m$ to receive $P$ and assigning the remainder to $Q$. Use comparable follow-up and assess the same response variable in both groups. Its advantage is simplicity and freedom from previous-treatment carryover effects; its disadvantage is that between-animal variation enters the residual and can make a treatment contrast imprecise.

A randomized complete block design with matched pairs first forms $m$ pairs using pre-treatment characteristics such as initial disease severity, age or breed. Independently choose which animal in each pair receives $P$, with its partner receiving $Q$. The experimental units are animals; pairs are blocks. The average within-pair difference estimates the treatment contrast, and positive within-pair similarity can reduce its variance. Its advantage is control of known heterogeneity; its disadvantage is the need for useful matching, with fewer residual statistical degrees of freedom and little gain if the matching variables are uninformative. Do not construct pairs using outcomes observed after assignment.

A two-period crossover design randomly assigns half the animals to sequence $PQ$ and half to $QP$. Each animal receives both treatments in separate periods, with a scientifically justified interval between them and the same outcome assessment after each period. Animal blocks remove persistent between-animal differences, while the two sequences balance treatment against period. Its advantage is potentially high precision from within-animal comparisons; its disadvantage is vulnerability to carryover effects, changing disease state and irreversible effects. It is suitable only when comparing the treatments in both periods remains meaningful and residual effects of the first treatment are adequately controlled. A two-period crossover design does not by itself disentangle arbitrary treatment-specific carryover effects.

First agree the scientific question and primary response variable. Ask the vet about the disease's course, the proposed mechanism and duration of each treatment, the eligible population, baseline severity, and what outcome and follow-up time would represent worthwhile improvement. Is the disease transmissible, is recovery reversible, and can treating one cow affect another's outcome? These answers determine whether a crossover design is credible, whether the experimental unit should be a cow or a whole herd, and whether individual randomization would leave interference between groups. Agree welfare and rescue arrangements with the vet when deciding which comparisons are feasible; the statistical plan cannot determine these from an unfamiliar disease name.

Second agree feasible allocation and adequate independent replication. Discuss numbers of available cows and herds, variation in the chosen outcome, a scientifically meaningful treatment difference, and the desired statistical power. Use these to plan sample size, rather than choosing a number solely from convenience. Discuss herd, lactation stage and initial severity as potential blocks in experimental design, then specify randomization, comparable management, concealed allocation and blinded outcome assessment where feasible. Repeated milk or health records from the same cow are observational units, not extra independent experimental units; pseudoreplication would give misleading standard errors. Availability of enough independent cows or herds, together with expected variation, governs the precision actually achievable.

A response variable is the outcome whose variation is described by a statistical model or whose change is compared across treatments. Its unit, measurement procedure and observation time must be specified. An outcome consisting of a feature count is one response per sketch, not one independent experimental response per feature.